ProShare Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-28,146
| Closed | -$130K | – | 1674 |
|
|
2019
Q1 | $130K | Buy |
28,146
+137
| +0.5% | +$649 | ﹤0.01% | 1546 |
|
|
2018
Q4 | $98K | Sell |
28,009
-5,558
| -17% | -$38.6K | ﹤0.01% | 1475 |
|
|
2018
Q3 | $338K | Sell |
33,567
-994
| -3% | -$7.93K | ﹤0.01% | 1291 |
|
|
2018
Q2 | $250K | Sell |
34,561
-2,458
| -7% | -$17.1K | ﹤0.01% | 1489 |
|
|
2018
Q1 | $224K | Sell |
37,019
-6,047
| -14% | -$49.9K | ﹤0.01% | 1488 |
|
|
2017
Q4 | $414K | Buy |
43,066
+470
| +1% | +$3.08K | ﹤0.01% | 1232 |
|
|
2017
Q3 | $378K | Buy |
42,596
+3,451
| +9% | +$35.6K | ﹤0.01% | 1068 |
|
|
2017
Q2 | $495K | Sell |
39,145
-1,864
| -5% | -$22.1K | ﹤0.01% | 970 |
|
|
2017
Q1 | $431K | Sell |
41,009
-10,179
| -20% | -$108K | ﹤0.01% | 1064 |
|
|
2016
Q4 | $471K | Buy |
51,188
+3,713
| +8% | +$41.9K | 0.01% | 1109 |
|
|
2016
Q3 | $560K | Sell |
47,475
-8,661
| -15% | -$132K | 0.01% | 904 |
|
|
2016
Q2 | $726K | Buy |
56,136
+331
| +0.6% | +$4.82K | 0.01% | 821 |
|
|
2016
Q1 | $892K | Sell |
55,805
-5,548
| -9% | -$105K | 0.01% | 741 |
|
|
2015
Q4 | $1.76M | Buy |
61,353
+4,305
| +8% | +$119K | 0.02% | 550 |
|
|
2015
Q3 | $1.62M | Sell |
57,048
-2,993
| -5% | -$110K | 0.02% | 531 |
|
|
2015
Q2 | $2.16M | Sell |
60,041
-147
| -0.2% | -$4.58K | 0.03% | 490 |
|
|
2015
Q1 | $1.75M | Buy |
60,188
+9,596
| +19% | +$254K | 0.02% | 604 |
|
|
2014
Q4 | $1.07M | Buy |
50,592
+7,098
| +16% | +$140K | 0.01% | 821 |
|
|
2014
Q3 | $843K | Sell |
43,494
-7,806
| -15% | -$123K | 0.01% | 1132 |
|
|
2014
Q2 | $801K | Sell |
51,300
-13,414
| -21% | -$217K | 0.01% | 1272 |
|
|
2014
Q1 | $1.34M | Buy |
64,714
+35,329
| +120% | +$701K | 0.02% | 1053 |
|
|
2013
Q4 | $379K | Buy |
+29,385
| New | +$408K | 0.01% | 1110 |
|
Other funds holding INSY
WS
ProShare Advisors's INSY Position: Q2 2019 in Review
ProShare Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 28,146 shares — an estimated $130K sold.
ProShare Advisors first reported a position in INSY in Q4 2013 and held it in 22 quarters. The position peaked at $2.16M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- ProShare Advisors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- ProShare Advisors sold 28,146 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $130K.
- ProShare Advisors first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 22 quarters.
- ProShare Advisors's Insys Therapeutics, Inc. position peaked at $2.16M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.